We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$188M
AUM Growth
+$10.4M
Cap. Flow
+$5.23M
Cap. Flow %
2.79%
Top 10 Hldgs %
18.44%
Holding
976
New
54
Increased
191
Reduced
228
Closed
305

Top Buys

Rank Stock Value
1
R icon
Ryder
R
+$492K
2
CTRA
Coterra Energy
CTRA
+$456K
3
VZ icon
Verizon
VZ
+$455K
4
STR
Sitio Royalties
STR
+$451K
5
AMT icon
American Tower
AMT
+$443K

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$455K
2
INGR icon
Ingredion
INGR
+$439K
3
IBM icon
IBM
IBM
+$424K
4
OKE icon
Oneok
OKE
+$398K
5
EPRT icon
Essential Properties Realty Trust
EPRT
+$376K

Sector Composition

Rank Sector Weight
1 Technology 23.7%
2 Real Estate 18.5%
3 Industrials 13.55%
4 Healthcare 8.87%
5 Consumer Discretionary 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEU icon
501
Vanguard FTSE All-World ex-US ETF
VEU
$70B
$5.35K ﹤0.01%
100
– –
VATE icon
502
INNOVATE Corp
VATE
$102M
$5.35K ﹤0.01%
+180
New +$5.26K
DYN icon
503
Dyne Therapeutics
DYN
$4.99B
$5.34K ﹤0.01%
+464
New +$6.03K
DOCS icon
504
Doximity
DOCS
$4.65B
$5.34K ﹤0.01%
165
-319
-66% -$10.6K
LNC icon
505
Lincoln National
LNC
$8.51B
$5.33K ﹤0.01%
237
+123
+108% +$3.66K
SVRA icon
506
Savara
SVRA
$1.14B
$5.29K ﹤0.01%
+2,713
New +$6.11K
PRTA icon
507
Prothena Corp
PRTA
$473M
$5.24K ﹤0.01%
+108
New +$5.71K
TMO icon
508
Thermo Fisher Scientific
TMO
$224B
$5.19K ﹤0.01%
+9
New +$5.07K
ASLE icon
509
AerSale
ASLE
$273M
$5.17K ﹤0.01%
300
-91
-23% -$1.62K
KN icon
510
Knowles
KN
$3.29B
$5.1K ﹤0.01%
300
– –
GEHC icon
511
GE HealthCare
GEHC
$32.9B
$5.09K ﹤0.01%
+62
New +$4.43K
VNQI icon
512
Vanguard Global ex-US Real Estate ETF
VNQI
$3.51B
$4.95K ﹤0.01%
+122
New +$5.16K
VSTO
513
DELISTED
Vista Outdoor Inc.
VSTO
$4.93K ﹤0.01%
178
– –
PLRX icon
514
Pliant Therapeutics
PLRX
$63.8M
$4.89K ﹤0.01%
+184
New +$5.24K
KYMR icon
515
Kymera Therapeutics
KYMR
$9.11B
$4.83K ﹤0.01%
163
+104
+176% +$3.35K
ITCI
516
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.82K ﹤0.01%
89
– –
KNSA icon
517
Kiniksa Pharmaceuticals
KNSA
$6.07B
$4.81K ﹤0.01%
+447
New +$5.89K
DAVA icon
518
Endava
DAVA
$160M
$4.77K ﹤0.01%
71
-140
-66% -$11K
DRLL icon
519
Strive US Energy ETF
DRLL
$302M
$4.73K ﹤0.01%
170
– –
DXCM icon
520
DexCom
DXCM
$33.8B
$4.65K ﹤0.01%
+40
New +$4.48K
SNDX icon
521
Syndax Pharmaceuticals
SNDX
$1.81B
$4.6K ﹤0.01%
+218
New +$5.42K
OLMA icon
522
Olema Pharmaceuticals
OLMA
$911M
$4.59K ﹤0.01%
+1,323
New +$5.4K
CDNA icon
523
CareDx
CDNA
$2.44B
$4.53K ﹤0.01%
496
+242
+95% +$3.1K
SOXX icon
524
iShares Semiconductor ETF
SOXX
$45.2B
$4.45K ﹤0.01%
30
– –
HWM icon
525
Howmet Aerospace
HWM
$112B
$4.24K ﹤0.01%
100
– –
19 20
21
22 23

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Truvestments Capital held 976 positions worth $188M, up 5.9% from $177M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Truvestments Capital's Q1 2023 filing shows 54 new, 191 increased, 228 reduced and 305 closed positions. Its largest new stake was Ameren: 1,544 shares worth $133K. The largest sale was Amazon, an estimated $455K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Real Estate and Industrials.

  • Truvestments Capital's largest Q1 2023 buy was Ameren: 1,544 shares worth $133K.
  • Truvestments Capital added most to Ryder in Q1 2023, an estimated $492K increase.
  • Truvestments Capital's biggest Q1 2023 reduction was Amazon, cutting an estimated $455K.
  • Truvestments Capital fully exited VanEck Morningstar Wide Moat ETF in Q1 2023, selling an estimated $75.3K.
  • Truvestments Capital's ten largest holdings make up 18% of its $188M portfolio in Q1 2023.
  • Truvestments Capital opened 54 new positions and closed 305 in Q1 2023.
  • Truvestments Capital's portfolio value rose 5.9% quarter-over-quarter to $188M.

Based on Truvestments Capital's 13F filing for Q1 2023, filed 12 May 2023.